On 26 and 27 May 2010, researchers from academia and industry will participate in a symposium to look at progress in building more physiologically accurate  models of human metabolism for applications in drug development and safety testing for cosmetics and chemicals to meet the new European REACH legislation.

[Download]

Attachments:

Download the flyer

508 Kb

Kirkstall Limited, the Sheffield-based developer of in vitro systems for testing the safety and efficacy of compounds are pleased to announce that Kirkstall’s Quasi-Vivo^TM in vitro compound testing system and Agenda 1’s SOLENT^TM solubilizing screen have been jointly selected by the CPhI judges as a finalist for the Innovation Award 2009.

Visit us at stand 8NE11

[Download pdf]

Kirkstall Limited., the Sheffield-based developer of in vitro systems for use in safety, efficacy and tissue engineering has announced the appointment of Professor David Tweats as a non-executive director.

[Download pdf]

33 leading cell and tissue engineering researchers from 8 Universities, 5 industrial companies, charities funding research and regulatory bodies met in Pisa on 27th of May to review and discuss their latest results in cell culture research.

[download pdf]

Kirkstall presents its inter-connected cell culture system, Quasi-Vivo^TM, at the latest Connect Yorkshire Investment Forum held at York Racecourse in June.

Dr Malcolm Wilkinson, Kirkstall CEO, said “ This event is a great way to meet serious investors . We are now in follow-up discussions with three groups with a view to them participating in our next round of financing which we aim to close by the end of the summer. A further benefit comes from the really professional advice and support you get from the Connect team of Mentors prior to the event. Getting your message across in a 10 minute presentation can be really tough but with the chance to rehearse and get expert feedback before you reach the Forum, both investors and the presenters should make the right connections”.

[Download pdf]